Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127794541 | 12779454 | 1 | I | 20120210 | 20120627 | 20160926 | 20160926 | EXP | PHHY2012IQ055376 | NOVARTIS | 34.03 | YR | F | Y | 0.00000 | 20160926 | CN | COUNTRY NOT SPECIFIED | IQ |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127794541 | 12779454 | 1 | SS | GLIVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | Y | 0 | 400 | MG | CAPSULE | QD | |||||
| 127794541 | 12779454 | 2 | SS | GLIVEC | IMATINIB MESYLATE | 1 | Oral | 600 MG, QD | Y | 0 | 600 | MG | CAPSULE | QD | |||||
| 127794541 | 12779454 | 3 | SS | GLIVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | Y | 0 | 400 | MG | CAPSULE | QD | |||||
| 127794541 | 12779454 | 4 | SS | GLIVEC | IMATINIB MESYLATE | 1 | Oral | 600 MG, QD | Y | 0 | 600 | MG | CAPSULE | QD | |||||
| 127794541 | 12779454 | 5 | SS | GLIVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | Y | 0 | 400 | MG | CAPSULE | QD | |||||
| 127794541 | 12779454 | 6 | PS | TASIGNA | NILOTINIB | 1 | Unknown | U | 22068 | CAPSULE | |||||||||
| 127794541 | 12779454 | 7 | C | METFORMINE | METFORMIN HYDROCHLORIDE | 1 | Oral | 1 DF, BID | U | 0 | 1 | DF | BID | ||||||
| 127794541 | 12779454 | 8 | C | DOSTINEX | CABERGOLINE | 1 | Oral | 0.5 DF, PER 03 DAYS | U | 0 | .5 | DF | |||||||
| 127794541 | 12779454 | 9 | C | GLUCOBAY | ACARBOSE | 1 | Oral | 1 DF, Q12H | U | 0 | 1 | DF | TABLET | Q12H | |||||
| 127794541 | 12779454 | 10 | C | SUPRAX//CEFIXIME | 2 | Unknown | 400 MG, QD | U | 0 | 400 | MG | QD | |||||||
| 127794541 | 12779454 | 11 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | UNK (SOS) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127794541 | 12779454 | 1 | Chronic myeloid leukaemia |
| 127794541 | 12779454 | 6 | Product used for unknown indication |
| 127794541 | 12779454 | 7 | Product used for unknown indication |
| 127794541 | 12779454 | 8 | Product used for unknown indication |
| 127794541 | 12779454 | 9 | Product used for unknown indication |
| 127794541 | 12779454 | 10 | Product used for unknown indication |
| 127794541 | 12779454 | 11 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127794541 | 12779454 | Abdominal pain upper | |
| 127794541 | 12779454 | Arthralgia | |
| 127794541 | 12779454 | Asthenia | |
| 127794541 | 12779454 | Blood creatinine increased | |
| 127794541 | 12779454 | Blood uric acid increased | |
| 127794541 | 12779454 | Bone pain | |
| 127794541 | 12779454 | Cough | |
| 127794541 | 12779454 | Diarrhoea | |
| 127794541 | 12779454 | Dizziness | |
| 127794541 | 12779454 | Dysgeusia | |
| 127794541 | 12779454 | Dysmenorrhoea | |
| 127794541 | 12779454 | Fatigue | |
| 127794541 | 12779454 | Flushing | |
| 127794541 | 12779454 | Headache | |
| 127794541 | 12779454 | Hyperglycaemia | |
| 127794541 | 12779454 | Hypertension | |
| 127794541 | 12779454 | Influenza | |
| 127794541 | 12779454 | Leukopenia | |
| 127794541 | 12779454 | Menstrual disorder | |
| 127794541 | 12779454 | Myalgia | |
| 127794541 | 12779454 | Nausea | |
| 127794541 | 12779454 | Neck pain | |
| 127794541 | 12779454 | Oedema | |
| 127794541 | 12779454 | Oedema peripheral | |
| 127794541 | 12779454 | Ovarian cyst | |
| 127794541 | 12779454 | Peripheral coldness | |
| 127794541 | 12779454 | Pyrexia | |
| 127794541 | 12779454 | Renal pain | |
| 127794541 | 12779454 | Skin discolouration | |
| 127794541 | 12779454 | Swelling | |
| 127794541 | 12779454 | Syncope | |
| 127794541 | 12779454 | Thrombocytosis | |
| 127794541 | 12779454 | Tonsillitis | |
| 127794541 | 12779454 | Tumour marker increased | |
| 127794541 | 12779454 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127794541 | 12779454 | 1 | 20100120 | 201507 | 0 | |
| 127794541 | 12779454 | 2 | 201507 | 201510 | 0 | |
| 127794541 | 12779454 | 3 | 201510 | 201512 | 0 | |
| 127794541 | 12779454 | 4 | 20151211 | 20151228 | 0 | |
| 127794541 | 12779454 | 5 | 20151228 | 201603 | 0 | |
| 127794541 | 12779454 | 7 | 201303 | 0 | ||
| 127794541 | 12779454 | 8 | 201303 | 0 | ||
| 127794541 | 12779454 | 9 | 201406 | 0 | ||
| 127794541 | 12779454 | 10 | 20141211 | 0 |